The landscape of dementia prognosis has developed significantly with the appearance of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks which will detect Alzheimer's pathology a long time before indications emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not dimi... https://samuell430kve0.blogoxo.com/profile